Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Ibex acquiring Oncotherapeutics

Ibex (TSE:IBT) will acquire Oncotherapeutics (Cranberry, N.J.), which holds exclusive rights

Read the full 118 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE